SH2B3 p.Ser103=
c.309C>T · VCV3953484
Likely benign
Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 0.00307%, afr)
Conditions
1
Inborn genetic diseases
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -9.9 | GERP -1.4 |
| Overall | ||
| CADD | 5.222 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
0.00307%
African / African-American · 2/65,148 alleles
Filtering AF
0.000509%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 0.000191%
Overall
0.00133%
2/150,924 alleles · very rare
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SH2B3
- Protein
- p.Ser103=
- Coding
- c.309C>T
- MANE Select
- NM_005475
- Type
- single nucleotide variant
- Location
- chr12:111418454 (GRCh38)
- Gene constraint
- LOEUF 1.35 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 63.45
- Residue 103
- a modified residue (phosphoserine); the 'disordered' region
Similar variants
- SH2B3 p.Ser103Phe Uncertain significance ★ ⚠ same residue
- SH2B3 p.Ala161Val Uncertain significance ★★ ⚠ same condition
- SH2B3 p.Ala174Thr Uncertain significance ★★ ⚠ same condition
- SH2B3 p.Ala300Thr Uncertain significance ★★ ⚠ same condition
- SH2B3 p.Arg221Met Uncertain significance ★★ ⚠ same condition
- SH2B3 p.Arg226Trp Uncertain significance ★★ ⚠ same condition
- SH2B3 p.Arg235Cys Uncertain significance ★★ ⚠ same condition
- SH2B3 p.Arg39Gln Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sh2b3-p-ser103 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown